Covid-19 roundup: Generic Merck pill to be made for lower-income countries; Gavi says it needs a $5B boost — report
The UN-backed Medicines Patent Pool has inked deals with 27 generic manufacturing companies to make cheaper versions of Merck’s Covid-19 antiviral molnupiravir for distribution in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
